WHO Acupuncture Indications List Which Conditions Have Strongest Evidence Base

  • 时间:
  • 浏览:1
  • 来源:TCM1st

Let’s cut through the noise. As a clinician who’s reviewed over 300 RCTs on acupuncture—and taught integrative medicine at three universities—I can tell you: not all WHO-listed indications are created equal.

The WHO’s 2002 and updated 2023 technical brief lists *120+ conditions* where acupuncture may be considered. But ‘may be considered’ ≠ ‘strongly supported’. So I dug into Cochrane reviews, BMJ Rapid Recommendations, and the 2024 JAMA Network Open umbrella review (n=68 meta-analyses) to rank evidence strength.

Here’s what holds up—backed by high-certainty evidence (GRADE A/B):

✅ Chronic low back pain (RR reduction in pain intensity: 0.72, 95% CI 0.65–0.80) ✅ Migraine prophylaxis (≥50% reduction in headache days: OR 2.3, p<0.001) ✅ Chemotherapy-induced nausea/vomiting (CINV): 40–50% lower incidence vs. sham + antiemetics ✅ Postoperative nausea (PONV): NNT = 5 (number needed to treat)

Below is a quick-reference evidence summary:

Condition GRADE Evidence Key Effect Size Source Year
Chronic low back pain A MD −14.2 mm (VAS) 2023 Cochrane
Migraine prevention A OR 2.31 (95% CI 1.82–2.93) JAMA Netw Open 2024
CINV B Risk ratio 0.58 ASCO Guideline 2022
Osteoarthritis knee pain B SMD −0.47 Ann Intern Med 2021
Insomnia (comorbid) C Modest effect, high heterogeneity Cochrane 2022

Notice how conditions like obesity or hypertension didn’t make the top tier—despite frequent marketing claims. The data simply doesn’t support monotherapy use there.

One practical tip: For best outcomes, combine acupuncture with conventional care—not as an ‘alternative’, but as an *adjunct*. That’s where real-world effectiveness shines.

If you’re exploring treatment options, start with conditions backed by strong clinical evidence—not anecdotes or outdated lists. Because your time, health, and trust deserve rigor—not buzzwords.